We have examined the effects of thiopentone, propofol and ketamine 3-300 mol litre 91 , 3.6 %, 2.4 rat MAC of isoflurane, 3.0 %, 2.4 rat MAC of halothane and morphine 0. and 0.7 nmol / min / mg protein in cortical and cerebellar preparations, respectively. At clinically relevant concentrations none of the agents tested influenced the uptake process. Our data suggest that the uptake of glutamate is not a major target site for anaesthetic or analgesic agents. (Br. J. Anaesth. 1995; 75: 61-65) 
Glutamate is probably the major excitatory neurotransmitter in the brain, acting on NMDA, AMPA, kainate and metabotrophic receptors [1] . Net synaptic glutamate concentrations result from a balance between release and reuptake, and potential secretagogues may affect either or both of these processes. Excess glutamate release and the potential for excitotoxicity which may occur during cerebral ischaemic episodes [2] [3] [4] represents a real clinical problem that may be exacerbated by inappropriate use of anaesthesia.
The glutamate transporter belongs to a large family of Na ; -dependent proteins [5] [6] [7] [8] [9] that functionally represent the major mechanism for clearing the synaptic cleft of released neurotransmitter. To date, eukaryotic cDNA encoding three distinct glutamate uptake transporters have been identified and named EAACl (524 amino acids with 10 transmembrane domains), GLAST (543 amino acids with six transmembrane domains) and GLT-1 (573 amino acids with eight transmembrane domains). Km values (for glutamate) for these transporters vary, with GLT-1 (~ 2 mol litre 91 ) displaying the highest affinity followed by EAACl (~ 12 mol litre
91
) and GLAST (~ 77 mol litre
), although some overlap may occur between EAACl and GLAST [9] . There is compelling evidence to implicate a role for these glutamate transporters in the pathology of neurodegenerative diseases such as amyotrophic lateral sclerosis, where a reduction in transporter numbers was observed in patients compared with disease-free controls [10] . In addition, dysfunction of glutamate transport has been noted in epilepsy and cerebral ischaemia [10] .
In this study we have examined the effects of i.v. and volatile anaesthetic and opioid analgesic agents on uptake of [ 3 H]glutamate into rat cerebrocortical and cerebellar synaptosomes in order to assess their potential as indirect modulators of synaptic glutamate concentrations. A preliminary account of this work has been presented previously [11] .
Materials and methods

SYNAPTOSOMAL PREPARATION
Female Wistar rats (200-250 g) were killed by cervical dislocation and decapitation. The brain was removed rapidly and the cerebellum placed in 4 ml of ice-cold sucrose buffer 1 (sucrose 0.32 mol litre 91 and HEPES 0.022 mol litre
91
). The cortex was detached from its internal structures and again placed in sucrose buffer 1 (10 ml). The cortex and cerebellum were homogenized using 10 up-down strokes at 700 rpm of a glass Teflon tight-fit Potter S homogenizer. The homogenate was spun at 1000 g for 10 min at 4 °C in a Biofuge 28RS Heraeus Sepatech centrifuge and the supernatant removed. The supernatant was pipetted gently onto six prepared Percoll gradients (23 %, 15 %, 10 % and 3 % in sucrose buffer 1), and centrifuged at 20 000 g for 10 min at 4 °C [12] . After centrifugation, fractions 3 and 4 (corresponding to interfaces 15 % and 23 %) were pipetted into a cold plastic tube and the mixture washed twice (by centrifuging at 20 000 g /4 °C/10 min) with prepared Krebs-HEPES buffer, pH 7. EFFECT OF ANAESTHETIC AGENTS Synaptosomes were preincubated for 15 min at 37 °C in the presence of the anaesthetic agent, that is with propofol, ketamine or thiopentone (3-300 mol litre 91 ), morphine 0.1-10 mol litre 91 , 3 % halothane or 3.6 % isoflurane. Isoflurane and halothane were pre-equilibrated for 15 min using a precalibrated Fluotec 3 vaporizer with humidified air 2.0 litre min 91 at 37 °C as the carrier gas. In propofol experiments, DMSO (the vehicle for propofol) was used as a control. As a positive control, synaptosomes were also preincubated at 37 °C with the specific uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylate (L-trans-PDC) 0.01-100 mol litre 91 for 15 min. Reactions were terminated as above and the filters extracted overnight using OptiPhase "Safe" as a scintillant.
MISCELLANEOUS METHODS
Aqueous isoflurane and halothane concentrations were confirmed by gas chromatography [13] using a Perkin Elmer 8410 gas chromatograph fitted with a 30-m megabore DB-17 column (Fisons), and a flame ionization detector. The injector, detector and oven temperatures were 120 °C, 100 °C and 90 °C, respectively. Helium was used as a carrier gas. Krebs-HEPES buffer 500 l was gassed with isoflurane (3.6 % vaporizer setting) or halothane (3 % vaporizer setting) for 15 min. n-Heptane 200 l was then added to 200 l of buffer to extract dissolved gas. Aliquots (1.5 l) of the organic layer were then injected onto the column. Volatile concentration was measured as the integrated peak height and compared with a known standard curve. Protein was measured [14] using bovine serum albumin as a standard. 
Discussion
In this study we found that cerebrocortical and cerebellar synaptosomes took up [ -dependent [5] [6] [7] [8] [9] and L-trans-PDC sensitive manner [16] . The rapid uptake kinetics are consistent with the need to rapidly clear the synaptic cleft of glutamate. Moreover, the Km and Vmax values were consistent with a report where cerebrocortical and cerebellar synaptosomes displayed Km and Vmax values of 5.2 mol litre 91 and 2.7 nmol / min / mg protein and 1.9 mol litre 91 and 0.5 nmol / min / mg protein, respectively [15] . While our data were consistent with previous work on synaptosomes, it is interesting that only the Km value for cerebrocortical synaptosomes was close to that of EEAC1, the neuronal specific transporter [9] . Km values of 2.2 mol litre 91 in cerebellum are more akin to those of GLT-1, located on astrocytes [9] . However, the presence of astrocytes in our synaptosome preparation [12] is unlikely and the reason for these small differences remains unclear.
There are few studies describing an interaction of anaesthetic agents with glutamate release and no detailed examination of uptake. In the rabbit, pentobarbitone, isoflurane and propofol did not affect in vivo glutamate concentrations measured in the dorsal hippocampus by microdialysis, suggesting that in the hippocampus at least, glutamate does not cause "anaesthesia" [17] . At variance with this hypothesis is the observation that in vitro, glutamate release (basal-and K ; -stimulated) from the guineapig hippocampus was inhibited by ethanol. Inhibition was more pronounced in fetal tissue [18] . Moreover, riluzole, a novel anaesthetic agent which in rats produces loss of righting reflex, prolongs sleep times to thiopentone and ketamine, and reduces halothane MAC, also reduces release of glutamate [19, 20] . In addition to these conflicting (inhibition / no effect) reports, enflurane was found to stimulate glutamate release from mouse cortical synaptosomes [21] . Release from cerebellum, diencephalon / pons and medulla oblongata was unaffected. The authors also noted that kainic acid, an inhibitor of glutamate uptake, did not affect enflurane stimulation of glutamate release, suggesting that enflurane (in common with isoflurane and halothane in this study) does not interact with the glutamate transporter. The stimulatory effects of enflurane on glutamate release may partly explain the seizure potential of this agent [22] . In our hands we have clearly demonstrated that at clinically relevant concentrations, propofol, thiopentone, ketamine, halothane and isoflurane failed to influence the uptake of [ Opioids represent an important class of therapeutic agents used in the preoperative, intraoperative and postoperative periods. Their presumed mechanism of action is via reduction in neurotransmission. Opioids inhibit neurotransmitter release primarily by closing voltage-sensitive Ca 2; channels and by hyperpolarizing the cell membrane [23] . While opioids also inhibit adenylyl cyclase to reduce cAMP formation, a definite role for cAMP in the immediate control of release remains to be determined [23] . In rat cerebrocortical slices, Bradford, Crowder and White [24] showed that and opioids inhibited veratrine-stimulated release of glutamate, with morphine (10 mol litre
91
) inhibition of glutamate release and 45 Ca 2; uptake amounting to 116 % and 85 %, respectively. No studies were performed on the uptake process. In addition, there is indirect evidence to support a role for opioid inhibition of glutamate release in guineapig hippocampus where dynorphins appear to block the induction of longterm potentiation, a response attributed to glutamate production [25] . Our data suggest that inhibition of glutamate release observed in these studies does not involve enhanced glutamate uptake.
In summary, we found that the range of anaesthetic-analgesic agents studied failed to affect glutamate uptake and any effects observed in subsequent studies of glutamate release are likely to involve direct modulation of the release process.
